Thank you so much for that.
Mr. Thibeault, thank you so much for coming.
This is part of your core advocacy. As you mentioned, we invented insulin and played a big part in advancing GLP-1, and you mentioned that we don't produce either of those. It's Canadian IP, yet we don't make money off of it.
From your perspective, tell us a bit about what you see as the biggest gaps and what we can do to address those.